No single neurotransmitter level is established as a general cause of amnesia. Memory involves several chemical signaling systems, and their activity varies by brain region, circuit, memory task and disease. Acetylcholine has a well-known connection to memory impairment in Alzheimer disease, but that does not make low acetylcholine a universal explanation or a routine diagnostic finding.
Why there is no single “amnesia level”
Neurotransmitters are released locally and dynamically, as neurons communicate. A change measured in one brain region during a particular task cannot be treated as a whole-brain reading or a threshold that explains every person’s memory loss. Experimental studies have observed changes in acetylcholine, glutamate, GABA, dopamine and noradrenaline during memory-related tasks, with changes correlated with neuronal activity; they do not establish one direction of change that applies to all memory or amnesia. A 2007 review of extracellular neurotransmitter levels during memory formation describes this region- and task-specific research.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Neuroscience | $194.99 | Buy on Amazon |
| 2 |
|
Principles of Neural Science, Sixth Edition | $150.99 | Buy on Amazon |
| 3 |
|
Neuroscience: Exploring the Brain, Enhanced Edition: Exploring the Brain, Enhanced Edition | $130.75 | Buy on Amazon |
| 4 |
|
Neuroscience | $155.03 | Buy on Amazon |
| 5 |
|
The Neuroscience of Pain, Anesthetics, and Analgesics | $384.10 | Buy on Amazon |
As an Amazon Associate I earn from qualifying purchases.
In-vivo microdialysis can monitor extracellular neurotransmitters in discrete central nervous system regions in research settings. Such measurements are not equivalent to a general blood test or a consumer whole-brain neurotransmitter test for diagnosing amnesia. The review describes microdialysis as a tool for investigating specific memory processes, not as a universal clinical diagnostic.
Recommended Free Tools
Which neurotransmitters have been studied?
These systems are best understood as participants in different processes, not as a ranked list of chemicals where one “memory level” predicts amnesia. The evidence includes experimental memory tasks and reviews of reconsolidation; those findings do not, by themselves, establish a cause of clinical amnesia.
#1 Best Overall
| System | What the cited work examines | What it does not establish |
|---|---|---|
| Acetylcholine | Attention and memory-related processes; cholinergic changes in Alzheimer disease and a treatment rationale for cholinesterase inhibitors. Blokland’s 1995 review and a 2018 review of Alzheimer disease discuss these issues. | A universal low-acetylcholine cause of amnesia or a general memory test threshold. |
| Glutamate and GABA | Memory formation and reconsolidation in experimental work, including animal studies. Reviews cover these systems alongside other transmitters. The 2018 reconsolidation review and a 2012 transporter review provide this context. | A specific human neurotransmitter level or transporter established as a general cause of amnesia. |
| Dopamine and noradrenaline | Changes during memory formation and roles in reconsolidation have been studied in particular tasks and systems. The 2007 review and the 2018 review describe this experimental literature. | A single direction of change that predicts memory loss across regions, memory types or diseases. |
| Serotonin | Reconsolidation and transporter-related memory research, much of it experimental. A 2018 review and a 2012 review discuss these topics. | A clinically validated serotonin-level test that identifies the cause of an individual’s amnesia. |
Acetylcholine and Alzheimer disease: a specific connection
Alzheimer disease is the clearest disease example in the sources. The disease is associated with loss of cholinergic neurons in the basal forebrain and their projections to cortical and limbic areas, alongside impaired memory. Cholinesterase inhibitors increase acetylcholine availability at synapses and are used as symptomatic treatments for Alzheimer disease dementia. This treatment rationale is disease-specific; it does not prove that low acetylcholine alone explains amnesia generally or that an acetylcholine-raising product prevents or reverses it. The 2018 review in Brain describes the cholinergic system and treatment context.
The interpretation also deserves care. In a 1995 review, A. Blokland argued that evidence for acetylcholine’s pivotal, specific role in learning and memory had been overstated, writing: “On basis of the available data, ACh seems to be more specifically involved in attentional processes than in learning and memory processes.” A separate discussion notes that the relationship between reduced cholinergic markers and cognitive decline in dementia may be less straightforward than often assumed. Alzheimer-related cholinergic changes matter, but they are not a complete one-chemical account of memory.
Rank #2
Why findings from memory experiments do not diagnose amnesia
Memory formation, attention, retrieval and reconsolidation are distinct processes. Findings also depend on the brain region, circuit, receptor and task under study. For example, a 2018 review of reconsolidation discusses dopamine, serotonin, noradrenaline, glutamate, GABA and acetylcholine, and reports that several systems may promote destabilization of reactivated memories in experimental work. How those systems interact across memory types and regions remains incompletely understood. That review concerns experimental reconsolidation research, not a clinical test for amnesia.
Free tools Windows power users keep installed
One-click scans. No signup required.
A 2012 review of GABA, glutamate, dopamine and serotonin transporters likewise describes transporter roles in memory formation and chemically induced amnesia as relatively little explored, discussing experimental animal findings. These results cannot be translated into a claim that a particular transporter or neurotransmitter level causes human amnesia. The review’s scope is transporter research, not an established human diagnostic threshold.
Rank #3
- Path of Discovery boxes by leading experts in the field (including Nobel Prize winners) showcase actual research experiences, illuminating real-life paths to scientific discovery.
- Illustrations and animations make complex concepts easier to understand.
- A neuroanatomy atlas insert (Appendix to Chapter 7) provides large images that highlight the anatomy of the brain, along with a self-quiz that gives students an opportunity to check their understanding.
- Of Special Interest boxes provide interesting facts and topics that connect theory with real-life neuroscience applications.
- Brain food boxes provide additional information on key topics.
Can neurotransmitter levels be tested for memory loss?
The sources describe region-specific measurements used in neuroscience research; they do not establish a general consumer whole-brain neurotransmitter test for diagnosing amnesia. A neurotransmitter finding from an animal task, a disease-related brain change and evidence that a treatment can help in a particular disease answer different questions. None should be collapsed into a stand-alone diagnosis or a universal cause.
Quick Recap
Best Value
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
